MoneyWorks4Me

Alembic Pharma gets EIR from USFDA for facility at Panelav

05 Apr 2019 Evaluate

Alembic Pharmaceuticals has received Establishment Inspection Report (EIR) from US Food & Drug Administration (USFDA) for the inspection carried out by them at the company’s Formulation Facility at Panelav during the period from October 22, 2018 to October 25, 2018.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..